Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
24.05
-0.38 (-1.56%)
Feb 13, 2026, 3:04 PM CST

SHE:002287 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,3872,3362,0402,0401,7661,480
Other Revenue
2.192.195.554.634.064.58
2,3892,3382,0452,0451,7701,485
Revenue Growth (YoY)
5.22%14.32%0.02%15.49%19.22%5.87%
Cost of Revenue
418.9419.55324.7325.52269.7217.36
Gross Profit
1,9701,9181,7201,7191,5011,268
Selling, General & Admin
1,3151,2801,1621,107986.35828.33
Research & Development
74.6166.7358.6355.0970.8260.32
Other Operating Expenses
100.0134.7632.2629.4728.5825.68
Operating Expenses
1,4901,3821,2531,1921,084915.16
Operating Income
480.41536.7467.52527.71416.45352.54
Interest Expense
-56.42-57.79-63.07-56.42-53.43-22.31
Interest & Investment Income
-4.1941.9216.96340.3358.1
Currency Exchange Gain (Loss)
-0.01-0.01-0.03-0.02-0.02-0.11
Other Non Operating Income (Expenses)
9.16-0.02-1.16-3.56-2.46-0.98
EBT Excluding Unusual Items
433.14483.08445.19484.68700.88387.24
Impairment of Goodwill
-----15.77-
Gain (Loss) on Sale of Investments
90.79100.3237.07-37.0820.69-
Gain (Loss) on Sale of Assets
3.07-0.320-0.07-0.35
Asset Writedown
0.25-0.58-0.3-1.22-0.35-0.04
Other Unusual Items
149.863.43162.1472.8282.5458.11
Pretax Income
677.05646.24644.41519.2787.91444.96
Income Tax Expense
66.4964.8765.2449.5677.0940.78
Earnings From Continuing Operations
610.56581.37579.18469.64710.83404.18
Minority Interest in Earnings
1.860.912.022.95.05-0.22
Net Income
612.42582.28581.2472.54715.88403.96
Net Income to Common
612.42582.28581.2472.54715.88403.96
Net Income Growth
3.09%0.19%22.99%-33.99%77.21%10.90%
Shares Outstanding (Basic)
534530530530529529
Shares Outstanding (Diluted)
534530530530529529
Shares Change (YoY)
0.77%0.03%-0.05%0.21%0.12%0.03%
EPS (Basic)
1.151.101.100.891.350.76
EPS (Diluted)
1.151.101.100.891.350.76
EPS Growth
2.30%0.15%23.05%-34.13%77.01%10.87%
Free Cash Flow
568.66201.31458.5913.29909.35-101.7
Free Cash Flow Per Share
1.060.380.860.031.72-0.19
Dividend Per Share
0.6000.3800.4800.3900.5900.340
Dividend Growth
25.00%-20.83%23.08%-33.90%73.53%-2.86%
Gross Margin
82.47%82.06%84.12%84.08%84.77%85.36%
Operating Margin
20.11%22.96%22.86%25.81%23.52%23.74%
Profit Margin
25.63%24.91%28.42%23.11%40.43%27.20%
Free Cash Flow Margin
23.80%8.61%22.42%0.65%51.36%-6.85%
EBITDA
605.33644.7552.96604.13476.77396.33
EBITDA Margin
25.34%27.57%27.04%29.54%26.93%26.69%
D&A For EBITDA
124.9210885.4376.4260.3243.79
EBIT
480.41536.7467.52527.71416.45352.54
EBIT Margin
20.11%22.96%22.86%25.81%23.52%23.74%
Effective Tax Rate
9.82%10.04%10.12%9.54%9.78%9.17%
Revenue as Reported
2,3892,3382,0452,0451,7701,485
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.